CLINICAL_TRIALS
ClinicalTrials.gov record update
REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04756505
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:24.030104+00:00
- Published At
- 2023-12-27T00:00:00+00:00
- Record Updated At
- 2023-12-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Anatomic Stage IV Breast Cancer AJCC v8", "Hormone Receptor Positive Breast Adenocarcinoma", "Metastatic Breast Carcinoma", "Metastatic HER2 Negative Breast Adenocarcinoma", "Prognostic Stage IV Breast Cancer AJCC v8"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-12-27"- protocolSection.identificationModule.nctId
"NCT04756505"- protocolSection.identificationModule.officialTitle
"REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.